Merit Medical Systems Quarterly Cash Flow Statement
NASDAQ: MMSIHealth CareMedical/Dental InstrumentsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Merit Medical Systems free cash flow
In the quarter ended Jun 30, 2026, Merit Medical Systems generated $69.3 million of operating cash flow and spent $17.3 million on capital expenditures. That left free cash flow of $51.9 million, a free-cash-flow margin of 12.4% of revenue. Free cash flow was down 25.3% from the prior year's $69.6 million.
Summary generated from market data by MetaCap's automated system. Methodology
Merit Medical Systems cash flow statement (quarterly)
| Quarter (USD) | Q2 20262026-06-30 | Q1 20262026-03-31 | Q4 20252025-12-31 | Q3 20252025-09-30 | Q2 20252025-06-30 | Q1 20252025-03-31 | Q4 20242024-12-31 | Q3 20242024-09-30 | Q2 20242024-06-30 | Q1 20242024-03-31 | Q4 20232023-12-31 | Q3 20232023-09-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | 38.80M | 40.99M | 38.01M | 27.75M | 32.58M | 30.15M | 27.95M | 28.44M | 35.73M | 28.24M | 27.63M | 25.83M |
| Net Income growth (YoY) | +19.10% | +35.98% | +35.99% | -2.42% | -8.80% | +6.75% | +1.15% | +10.10% | +76.47% | +36.41% | -17.28% | +69.16% |
| Depreciation & Amortization | 31.00M | 30.50M | 31.54M | 31.32M | 31.00M | 29.29M | 28.62M | 26.40M | 24.09M | 23.60M | 23.63M | 24.04M |
| Stock-Based Compensation | 12.91M | 8.96M | 9.90M | 13.61M | 10.87M | 9.08M | 9.52M | 6.71M | 7.01M | 5.23M | 5.99M | 5.80M |
| Change in Working Capital | -35.14M | -7.46M | -2.68M | -8.87M | -4.42M | -14.62M | -3.55M | -8.72M | 7.75M | -18.80M | 1.82M | -9.11M |
| Operating Cash Flow | 69.28M | 40.68M | 98.51M | 74.98M | 83.31M | 40.57M | 68.74M | 47.33M | 68.51M | 36.22M | 62.25M | 51.07M |
| Capital Expenditures | -17.33M | -16.01M | -24.46M | -22.44M | -13.75M | -21.06M | -3.47M | -9.36M | -10.63M | -11.68M | -7.14M | -8.60M |
| Investing Cash Flow | -110.13M | 7.73M | -50.34M | -24.07M | -143.35M | -29.64M | -214.45M | -115.67M | -16.49M | -22.05M | -8.34M | -9.25M |
| Debt Issued | — | — | — | — | — | — | — | — | — | — | 718.70M | 20.22M |
| Debt Repaid | — | — | — | — | — | — | -23.00M | -52.00M | 0 | -24.06M | -188.00M | -73.15M |
| Financing Cash Flow | 948.00K | -6.29M | 5.06M | -365.00K | 4.35M | 6.96M | 2.43M | -47.57M | 3.14M | -18.00M | 472.81M | -54.55M |
| Net Change in Cash | -39.34M | 41.70M | 53.99M | 50.65M | -53.68M | 18.83M | -146.51M | -113.44M | 54.73M | -5.16M | 528.41M | -13.42M |
| Free Cash Flow | 51.95M | 24.67M | 74.05M | 52.54M | 69.56M | 19.51M | 65.27M | 37.97M | 57.88M | 24.53M | 55.11M | 42.47M |
This table shows 12 quarterly periods of Merit Medical Systems's cash flow statement, from Q2 2026 back to Q3 2023, across 12 line items including net income, depreciation & amortization, stock-based compensation. Values in USD; B = billions, M = millions. Fiscal periods follow MMSI's reporting calendar. What is a cash flow statement?